Leslie believes Imugene can do one better than drugs generating 7 billion dollars annually.
They may actually have a few drugs that can deliver such revenue.
Massive price catalysts are on the horizon.
I'll be buying all the way up to the partnership. Which I feel will come sometime during Phase 2. If we have positive data up to that point hold onto your hats.
Add to My Watchlist
What is My Watchlist?
